Transactions: Healthcare
Filter
Initial public offering of Alligator Bioscience AB (SE) on Nasdaq Stockholm – SEK 483 million
Divestment of BioPhausia AB (SE) to Karo Pharma AB (SE) by Medivir AB (SE) — Enterprice value SEK 908 million
Directed new share issue in Hansa Medical AB (SE) — SEK 185 million
Rights issue in PledPharma (SE) — SEK 406 million
Placing of shares in Capio AB (SE) — SEK 980 million
Cash offer for Exiqon A/S (DK) by QIAGEN N.V. (NL) — DKK 736 million
Placing of shares in Attendo AB (SE) — SEK 1.9 billion
Initial public offering of Wilson Therapeutics AB AB (SE) on Nasdaq Stockholm – SEK 480 million
Directed new share issue in NEXT Biometrics (NO) — NOK 165 million